Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
Dul M, Alali M, Ameri M, Burke MD, Craig CM, Creelman BP, Dick L, Donnelly RF, Eakins MN, Frivold C, Forster AH, Gilbert PA, Henke S, Henry S, Hunt D, Lewis H, Maibach HI, Mistilis JJ, Park JH, Prausnitz MR, Robinson DK, Hernandez CAR, Ross C, Shin J, Speaker TJ, Taylor KM, Zehrung D, Birchall JC, Jarrahian C, Coulman SA. Dul M, et al. Among authors: forster ah. J Control Release. 2023 Sep;361:236-245. doi: 10.1016/j.jconrel.2023.07.001. Epub 2023 Aug 8. J Control Release. 2023. PMID: 37437849 Free article.
M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).
Mills JS, Jayashi Flores CM, Reynolds S, Wun C, Calcutt A, Baker SB, Murugappan S, Depelsenaire ACI, Dooley J, Fahey PV, Forster AH, Pandey M, Good MF. Mills JS, et al. Among authors: forster ah. NPJ Vaccines. 2020 Aug 7;5(1):74. doi: 10.1038/s41541-020-00222-2. eCollection 2020. NPJ Vaccines. 2020. PMID: 32802413 Free PMC article.
Erratum: Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).
Mills JS, Jayashi Flores CM, Reynolds S, Wun C, Calcutt A, Baker SB, Murugappan S, Depelsenaire ACI, Dooley J, Fahey PV, Forster AH, Pandey M, Good MF. Mills JS, et al. Among authors: forster ah. NPJ Vaccines. 2020 Sep 3;5:80. doi: 10.1038/s41541-020-00233-z. eCollection 2020. NPJ Vaccines. 2020. PMID: 32944294 Free PMC article.
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial.
Baker B, Bermingham IM, Leelasena I, Hickling J, Young PR, Muller DA, Forster AH. Baker B, et al. Among authors: forster ah. Vaccines (Basel). 2023 Nov 17;11(11):1725. doi: 10.3390/vaccines11111725. Vaccines (Basel). 2023. PMID: 38006057 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33574333
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
Forster AH, Witham K, Depelsenaire ACI, Veitch M, Wells JW, Wheatley A, Pryor M, Lickliter JD, Francis B, Rockman S, Bodle J, Treasure P, Hickling J, Fernando GJP. Forster AH, et al. PLoS Med. 2020 Mar 17;17(3):e1003024. doi: 10.1371/journal.pmed.1003024. eCollection 2020 Mar. PLoS Med. 2020. PMID: 32181756 Free PMC article. Clinical Trial.
33 results